Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Joon Soo Hahm,Gwang Ho Mun,Hang Lak Lee,Chang Soo Eun,Joon Yong Park,Dong Soo Han,Ho Soon Choi,You Hern Ahn

Clin Mol Hepatol. 2002;8(1):80-89. Published online January 1, 1970

View: 2345 Download: 12

Nam Ik Han,Sang Wook Choi,Young Sok Lee,Chang Don Lee,Kyu Won Chung,Hee Sik Sun

Clin Mol Hepatol. 2000;6(3):360-369. Published online January 1, 2000

View: 2140 Download: 20

Shuhei Fukunaga, Tomoyuki Nakane, Michita Mukasa, Hidetoshi Takedatsu, Takumi Kawaguchi

Received April 7, 2024 Accepted May 10, 2024

DOI: https://doi.org/10.3350/cmh.2024.0233 [Accepted]

View: 382 Download: 30 Crossref: 1

1 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5409	MAFLD: How is it different from NAFLD?
Viewed By 5220	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5098	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search